Google AI
The Times Australia

Times Media

Pierre Fabre initiates a "First in Human" clinical trial for an innovative monoclonal antibody (W0180) targeting the VISTA checkpoint in patients with solid tumors

Pierre Fabre initiates a "First in Human" clinical trial for an innovative monoclonal antibody (W0180) targeting the VISTA checkpoint in patients with solid tumors

TOULOUSE, France, Nov. 9, 2020 /PRNewswire/ -- Pierre Fabre announced today the initiation of an international Phase I clinical study in patients with relapsed or refractory solid tumors for its investigational product W0180, an innovative monoclonal antibody targeting VISTA, developed by Pierre Fabre Medical Care R&D teams. The study...

Read more: Pierre Fabre initiates a "First in Human" clinical trial for an innovative monoclonal antibody (W018...

More Articles …

  1. OrbusNeich® Medical and P+F Products & Features® announce new partnership-PR Newswire APAC
  2. The world's largest RCT investigating use of MagicTouch PTA Sirolimus Coated balloon for peripheral artery disease kicks off to a flying start
  3. Global Beauty & Wellness Awards announces Best Cosmetics and Hotels in the World 2020-PR Newswire APAC
  4. Centennial Property Group Announces Offering of AUD$100Million Senior Secured Loan Note Program-PR Newswire APAC
  5. ASEAN Marketing Summit 2020 -- The Biggest Marketing Summit in ASEAN is Back-PR Newswire APAC
  6. Amcor reports strong first quarter results and raises outlook for fiscal 2021-PR Newswire APAC
  7. Semaglutide 2.4 mg injection demonstrated significant weight loss versus placebo when added to intensive behavioural therapy
  8. New football simulator Football for Friendship World to be released on World Football Day
  9. FP Markets recognised as 'Best FX Broker Australia' for 2020
  10. Fuji Xerox Strengthens Synergies Within Fujifilm Group to Create Growth Globally-PR Newswire APAC

Business Times

Scam Prevention Must Become a Business Resilience Priority

As Australia marks Scam Awareness Week, organisations are being urged to rethink their approach to scam prevention ...

What Insurance Customers Really Want from Omnichannel Communicati…

Despite years of investment in digital engagement, from rolling out mobile apps and online portals to digital communication...

Times Media Group launches four new Australian local publications…

ByronBay.au, TheCairnsTimes.com.au, AirlieTimes.com.au and NoosaTimes.com have been launched as part of an expanding networ...

Technology

Old Phones, Big Impact: Queensland …

Cairns Regional Council has topped MobileMuster’s FY26 council collection figures in Queensland, w...

Local News

Psychology clinic in Tasmania opens…

In response to Tasmania’s growing mental health crisis, a new purpose-built, multi-disciplinary me...

Culture

Psychosocial Risk Rules Have Changed: As an E…

Since 1 July, Australian organisations have faced strengthened expectations around how they manage...

Travel

Cairns Esplanade Lagoon — the stage where Cai…

“All the world's a stage.” Shakespeare wasn't writing about Cairns when he penned that famous lin...

The Times Features

You joined social media to communicate — when did you a…

There was once a fairly simple bargain at the heart of social media. You joined a network. You c...

Psychosocial Risk Rules Have Changed: As an Employer, A…

Since 1 July, Australian organisations have faced strengthened expectations around how they manage...

Why Spring Is the Real Deadline for a WA Lawn Renovatio…

Every spring, I watch the same thing happen. A homeowner looks at their lawn properly for the firs...